Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
GMAB:CPH
Genmab
DKK 1 694,00
+0,24%
(+4,00) 1D
1 Mei, 17:00:00 GMT+2  ·   DKK
All symbols
SymbolPriceChange% Change
Generating top insights for GMAB...
Open
DKK 1 691,00
High
DKK 1 695,00
Low
DKK 1 670,50
Mkt. cap
104,87 mjd
Avg. vol.
125,26 k
Volume
42,25 k
52-wk high
DKK 2 257,00
52-wk low
DKK 1 204,50
Shares outstanding
62,35 m
No. of employees
3 k
News stories
From sources across the web
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab
CEOJan G. J. van de Winkel
Employees2,97 k
Founded1999
Headquarters-
Sector-
Websitegenmab.com
Previous reportsAll values in DKK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in DKK
Des. 2023
Mrt. 2024
Jun. 2024
Sep. 2024
Revenue
4,68 mjd
4,14 mjd
5,40 mjd
5,54 mjd
Cost of goods sold
-
-
-
273,00 m
Cost of revenue
-
-
-
273,00 m
Research and development expenses
-
-
-
2,28 mjd
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
865,00 m
Operating expense
-
-
-
3,15 mjd
Total operating expenses
-
-
-
3,42 mjd
Operating income
-
-
-
2,12 mjd
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
1,72 mjd
EBT excluding unusual items
-
-
-
1,59 mjd
Income tax expense
-
-
-
453,00 m
Effective tax rate
-
-
-
26,35%
Other operating expenses
-
-
-
-
Net income
-
-
-
1,27 mjd
Net profit margin
-
-
-
22,85%
Earnings per share
9,67
-
-
19,81
Interest and investment income
-
-
-
162,00 m
Interest expense
-
-
-
-18,00 m
Net interest expenses
-
-
-
144,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
2,20 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer